Dexco Statistics

Total Valuation

Dexco has a market cap or net worth of BRL 5.02 billion. The enterprise value is 10.98 billion.

Market Cap	5.02B
Enterprise Value	10.98B

Important Dates

The last earnings date was Tuesday, February 11, 2025.

Earnings Date	Feb 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Dexco has 808.36 million shares outstanding. The number of shares has decreased by -0.73% in one year.

Current Share Class	n/a
Shares Outstanding	808.36M
Shares Change (YoY)	-0.73%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	20.71%
Owned by Institutions (%)	20.12%
Float	306.18M

Valuation Ratios

The trailing PE ratio is 14.94 and the forward PE ratio is 27.62.

PE Ratio	14.94
Forward PE	27.62
PS Ratio	0.62
PB Ratio	0.76
P/TBV Ratio	0.87
P/FCF Ratio	50.65
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.48, with an EV/FCF ratio of 110.75.

EV / Earnings	32.59
EV / Sales	1.35
EV / EBITDA	6.48
EV / EBIT	21.72
EV / FCF	110.75

Financial Position

The company has a current ratio of 1.49, with a Debt / Equity ratio of 1.21.

Current Ratio	1.49
Quick Ratio	1.10
Debt / Equity	1.21
Debt / EBITDA	5.11
Debt / FCF	82.23
Interest Coverage	0.53

Financial Efficiency

Return on equity (ROE) is 5.25% and return on invested capital (ROIC) is 1.80%.

Return on Equity (ROE)	5.25%
Return on Assets (ROA)	1.45%
Return on Invested Capital (ROIC)	1.80%
Return on Capital Employed (ROCE)	2.74%
Revenue Per Employee	570,647
Profits Per Employee	23,673
Employee Count	14,228
Asset Turnover	0.46
Inventory Turnover	4.22

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.14% in the last 52 weeks. The beta is 0.87, so Dexco's price volatility has been lower than the market average.

Beta (5Y)	0.87
52-Week Price Change	-19.14%
50-Day Moving Average	6.09
200-Day Moving Average	7.17
Relative Strength Index (RSI)	52.98
Average Volume (20 Days)	2,185,035

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dexco had revenue of BRL 8.12 billion and earned 336.82 million in profits. Earnings per share was 0.42.

Revenue	8.12B
Gross Profit	1.96B
Operating Income	408.47M
Pretax Income	406.93M
Net Income	336.82M
EBITDA	1.52B
EBIT	408.47M
Earnings Per Share (EPS)	0.42

Full Income Statement

Balance Sheet

The company has 2.15 billion in cash and 8.15 billion in debt, giving a net cash position of -5.84 billion or -7.22 per share.

Cash & Cash Equivalents	2.15B
Total Debt	8.15B
Net Cash	-5.84B
Net Cash Per Share	-7.22
Equity (Book Value)	6.73B
Book Value Per Share	8.17
Working Capital	1.80B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.48 billion and capital expenditures -1.38 billion, giving a free cash flow of 99.11 million.

Operating Cash Flow	1.48B
Capital Expenditures	-1.38B
Free Cash Flow	99.11M
FCF Per Share	0.12

Full Cash Flow Statement

Margins

Gross margin is 24.18%, with operating and profit margins of 5.03% and 4.15%.

Gross Margin	24.18%
Operating Margin	5.03%
Pretax Margin	5.01%
Profit Margin	4.15%
EBITDA Margin	18.74%
EBIT Margin	5.03%
FCF Margin	1.22%

Dividends & Yields

This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 3.46%.

Dividend Per Share	0.22
Dividend Yield	3.46%
Dividend Growth (YoY)	-84.55%
Years of Dividend Growth	n/a
Payout Ratio	0.02%
Buyback Yield	0.73%
Shareholder Yield	4.19%
Earnings Yield	6.71%
FCF Yield	1.97%

Dividend Details

Stock Splits

The last stock split was on December 21, 2022. It was a forward split with a ratio of 1.1.

Last Split Date	Dec 21, 2022
Split Type	Forward
Split Ratio	1.1

Scores

Dexco has an Altman Z-Score of 1.11. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.11
Piotroski F-Score	n/a